Media Centre
Latest press releases
-
Lynparza granted Priority Review in the US for BRCA-mutated HER2-negative high-risk early breast cancer
-
AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
-
New analyses of two AZD7442 COVID-19 Phase III trials in high-risk populations confirm robust efficacy and long-term prevention
-
Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world less than 12 months after first approval
-
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director, Global Media Relations (Corporate)
+44 (0)1223 344 800
Angela Fiorin
Director, Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Chris Calland
Director, Global Media Relations (Oncology)
+44 (0)1223 344 800
Fiona Cookson
Director, Global Media Relations
(COVID-19 vaccine)
+44 (0)1223 344 800
Sinead Keller
Director, Global Media Relations
(COVID-19 vaccine)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
Brendan McEvoy
Head, US External Communications
+1 302 885 2677
Lisa Taylor
Senior Director, Corporate Communications (Alexion)
+1 857 338 9025
Amanda Talamonte
Manager, Global Media Relations
+44 (0)1223 344 800
Flavia Garcia
Manager, Global Media Relations
+44 (0)1223 344 800
